– Survey findings showed a majority of participants had a favorable experience injecting Acthar Gel via SelfJect, with a high level of satisfaction, confidence, convenience, and ease of use regarding ...
The Food and Drug Administration (FDA) has approved Mallinckrodt’s supplemental New Drug Application (sNDA) for the Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ ...
(RTTNews) - Specialty pharma company Mallinckrodt plc (MNK), Friday announced that the U.S. Food and Drug Administration approved a supplemental New Drug Application or SNDA for Acthar Gel Single-Dose ...
Acthar Gel was approved by the FDA for treatment of some autoimmune diseases including lupus in 1952. Below are answers to some questions you may have about this drug as you explore it as an option to ...
– Acthar Gel Single-Dose Pre-filled SelfJect Injector is a self-controlled, pre-filled delivery device1 for appropriate patients with a range of chronic and acute inflammatory and autoimmune ...
Please provide your email address to receive an email when new articles are posted on . The Acthar Gel SelfJect injector is indicated for acute exacerbations of multiple sclerosis and certain cases of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results